Systemic non-steroidal immunomodulators for oral lichen planus treatment —a scoping review

ConclusionAmong SNSI therapeutic options, methotrexate, and dapsone showed promising efficacy and safety. However, large-scale randomized clinical trials are still needed.Clinical relevanceSNSI have been used in the treatment of recalcitrant OLP; however, so far, it is not clear which are the best options. This scoping review highlights the potential use of methotrexate and dapsone.
Source: Clinical Oral Investigations - Category: Dentistry Source Type: research